21 CFR Part 822 - POSTMARKET SURVEILLANCE
- Subpart A - General Provisions (§§ 822.1 - 822.4)
- Subpart B - Notification (§§ 822.5 - 822.7)
- Subpart C - Postmarket Surveillance Plan (§§ 822.8 - 822.15)
- Subpart D - FDA Review and Action (§§ 822.16 - 822.23)
- Subpart E - Responsibilities of Manufacturers (§§ 822.24 - 822.28)
- Subpart F - Waivers and Exemptions (§§ 822.29 - 822.30)
- Subpart G - Records and Reports (§§ 822.31 - 822.38)
{'United States Code': [{'Title': '21', 'Section': '331', 'headtext': ' Prohibited acts', 'cleanpath': '/uscode/text/21/331'}, {'Title': '21', 'Section': '352', 'headtext': ' Misbranded drugs and devices', 'cleanpath': '/uscode/text/21/352'}, {'Title': '21', 'Section': '360i', 'headtext': ' Records and reports on devices', 'cleanpath': '/uscode/text/21/360i'}, {'Title': '21', 'Section': '360l', 'headtext': ' Postmarket surveillance', 'cleanpath': '/uscode/text/21/360l'}, {'Title': '21', 'Section': '371', 'headtext': ' Regulations and hearings', 'cleanpath': '/uscode/text/21/371'}, {'Title': '21', 'Section': '374', 'headtext': ' Inspection', 'cleanpath': '/uscode/text/21/374'}], 'Statutes at Large': [], 'Public Laws': [], 'Presidential Documents': []}